Vir Biotechnology, Inc. (NASDAQ:VIR) has 214 institutional investors with active 13F positions as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Mar, 2026 | 17,998,329 | 1,668,226 | 10.22% | $161,265,028.00 |
| BlackRock, Inc. | 31 Mar, 2026 | 16,330,103 | 362,447 | 2.27% | $98,470,521.00 |
| SB INVESTMENT ADVISERS (UK) LTD | 31 Mar, 2026 | 13,116,977 | -3,567,064 | -21.38% | $79,095,371.00 |
| ARCH Venture Management, LLC | 31 Mar, 2026 | 12,916,663 | 0 | 0.00% | $115,733,300.00 |
| ARCH Venture Management, LLC | 31 Mar, 2026 | 12,916,663 | 0 | 0.00% | $77,887,478.00 |
| VANGUARD GROUP INC | 31 Mar, 2026 | 12,548,944 | -250,437 | -1.96% | $75,670,133.00 |
| SB INVESTMENT ADVISERS (UK) LTD | 31 Mar, 2026 | 10,948,093 | -2,168,884 | -16.53% | $98,094,913.00 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 31 Mar, 2026 | 9,215,577 | 9,215,577 | 0.00% | $82,571,570.00 |
| GSK plc | 31 Mar, 2026 | 8,550,954 | 0 | 0.00% | $76,616,548.00 |
| GSK plc | 31 Mar, 2026 | 8,550,954 | 8,550,954 | 0.00% | $51,562,253.00 |
| State Street Corp | 31 Mar, 2026 | 7,141,094 | 911,539 | 14.63% | $63,984,202.00 |
| State Street Corp | 31 Mar, 2026 | 6,229,555 | 988,262 | 18.86% | $37,564,217.00 |
| VANGUARD CAPITAL MANAGEMENT LLC | 31 Mar, 2026 | 5,382,103 | 5,382,103 | 0.00% | $48,223,643.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 3,250,227 | 112,419 | 3.58% | $29,122,034.00 |
| FMR LLC | 31 Mar, 2026 | 3,158,416 | -478,714 | -13.16% | $19,045,246.00 |
| Goldman Sachs Group Inc | 31 Mar, 2026 | 3,137,808 | 1,616,006 | 106.19% | $18,920,982.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,854,205 | 175,060 | 6.53% | $25,573,682.00 |
| ADAR1 Capital Management, LLC | 31 Mar, 2026 | 2,744,714 | 2,744,714 | 0.00% | $24,592,637.00 |
| Morgan Stanley | 31 Mar, 2026 | 2,679,145 | -9,973 | -0.37% | $16,155,254.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Mar, 2026 | 2,657,843 | 329,636 | 14.16% | $23,819,795.00 |